Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sterile water is being investigated by University Tunis El Manar as a non-pharmacological/physical intervention for the rapid relief of acute renal colic pain associated with urolithiasis. Administered via intradermal injection at the site of maximal pain (thoraco-lumbar region), it is hypothesized to work through the gate control theory of pain or diffuse noxious inhibitory control (DNIC). By stimulating cutaneous mechanoreceptors and nociceptors, the injection creates a localized stinging sensation that potentially inhibits the transmission of visceral pain signals at the spinal cord level. This method offers a low-cost, non-systemic alternative to opioids like morphine, avoiding common systemic side effects such as respiratory depression, sedation, or nausea.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sterile water.